Invivyd, Inc. IVVD

NAS: IVVD | ISIN: US00534A1025 17/05/2024

2,400 USD (-2,04%)

(-2,04%) 17/05/2024

Grafiek Invivyd, Inc.

Grafiek Invivyd, Inc.

1 dag1d -2,04%
1 week1w 1,27%
1 maand1m 9,59%
3 maanden3m -41,46%
6 maanden6m 60,00%
1 jaar1j 69,01%
5 jaar5j -88,51%

Invivyd, Inc. in het nieuws

Toon enkel gratis nieuws

31 maart 2023 · IVVD Investors Have Opportunity to Lead Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

18 maart 2023 · INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI · Persbericht

15 maart 2023 · IVVD Investors Have Opportunity to Lead Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

23 februari 2023 · IVVD Investors Have Opportunity to Lead Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. Securities Fraud Lawsuit · Persbericht

18 februari 2023 · INVIVYD SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Invivyd, Inc. - IVVD, ADGI · Persbericht

2 februari 2023 · Bronstein, Gewirtz & Grossman, LLC Notifies Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (IVVD) Investors of Class Action and to Actively Participate · Persbericht

Profiel Invivyd, Inc.

Werknemers: 36

Aandelen Invivyd, Inc.

Beurswaarde: 286,36 miljoen USD

Effecten: 119,32 miljoen

Beta: 0,69

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe